Ambys Medicines and Takeda Announce Partnership to Pioneer First-in-Class Therapies for the Treatment of Serious Liver Diseases
Pharmaceutical Investing Phase 3 Trial of NINLARO (ixazomib) as Maintenance Therapy Met Primary Endpoint
Pharmaceutical Investing Takeda and TiGenix Announce Results of Second Acceptance Period for the Voluntary and Conditional Public Takeover Bid
Pharmaceutical Investing Takeda and TiGenix Announce Results of First Acceptance Period for the Voluntary and Conditional Public Takeover Bid of TiGenix
